Real-World Management of Trabectedin/Pegylated Liposomal Doxorubicin in Platinum-Sensitive Recurrent Ovarian Cancer Patients: A National Survey

Gabriella Ferrandina; Giulia Amadio; Ida Paris; Mariagrazia Distefano; Eleonora Palluzzi; Rosa de Vincenzo; Caterina Ricci; Giovanni Scambia

doi:10.1097/IGC.0000000000001058

Article info

Ovarian Cancer

Real-World Management of Trabectedin/Pegylated Liposomal Doxorubicin in Platinum-Sensitive Recurrent Ovarian Cancer Patients: A National Survey

Authors

Gabriella Ferrandina Department of Health Sciences and Medicine, University of Molise, Campobasso; Gynecologic Oncology Unit, Department Obstetrics/Gynecology, Fondazione “Policlinico Universitario A. Gemelli”, Rome; and Catholic University of Rome, Italy. PubMed articles Google scholar articles
Giulia Amadio Catholic University of Rome, Italy. PubMed articles Google scholar articles
Ida Paris Catholic University of Rome, Italy. PubMed articles Google scholar articles
Mariagrazia Distefano Catholic University of Rome, Italy. PubMed articles Google scholar articles
Eleonora Palluzzi Catholic University of Rome, Italy. PubMed articles Google scholar articles
Rosa de Vincenzo Gynecologic Oncology Unit, Department Obstetrics/Gynecology, Fondazione “Policlinico Universitario A. Gemelli”, Rome; and Catholic University of Rome, Italy. PubMed articles Google scholar articles
Caterina Ricci Catholic University of Rome, Italy. PubMed articles Google scholar articles
Giovanni Scambia Gynecologic Oncology Unit, Department Obstetrics/Gynecology, Fondazione “Policlinico Universitario A. Gemelli”, Rome; and Catholic University of Rome, Italy. PubMed articles Google scholar articles

Address correspondence and reprint requests to Gabriella Ferrandina, MD, Department of Health Sciences and Medicine, University of Molise, Campobasso Gynecologic Oncology Unit, Fondazione “Policlinico Universitario A. Gemelli,” L.go Agostino Gemelli 8 00168, Rome, Italia. E-mail: gabriella.ferrandina{at}gmail.com.

Citation

Ferrandina G, Amadio G, Paris I, et al

Real-World Management of Trabectedin/Pegylated Liposomal Doxorubicin in Platinum-Sensitive Recurrent Ovarian Cancer Patients: A National Survey

International Journal of Gynecologic Cancer 2017;27:1141-1148.

Publication history

Received November 30, 2016
Accepted February 15, 2017
First published July 1, 2017.

Online issue publication

July 01, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password